A representative from probiotics supplier Chr. Hansen told Nutritional Outlook that while probiotics are known for their gut-health benefits, this is the first time the company has investigated probiotics’ effects on NSAID-induced gastrointestinal damage.
Trends & Business
Thanks to a new encapsulation partnership, a water-soluble powder version of Algatech’s AstaPure asaxanthin ingredient is expected to launch in the coming months.
FrieslandCampina Domo says that its first human milk oligosaccharide (HMO) ingredient, which has now been granted EU Novel Food approval and Generally Recognized as Safe (GRAS) status in the U.S., will launch by the end of the year.
FDA announced today that it sent warning letters to four makers of “sun-protecting” nutricosmetic ingestible supplements for making illegal drug claims related to UV protection and skin cancer.
Health Canada’s letter of no objection means that Deerland Enzymes & Probiotics’ DE111 strain is no longer a Novel Food and can now be sold as a food ingredient without the need for premarket notification.
Janoušek’s expertise in natural Italian flavors, in particular, will help Synergy continue to grow its global business and innovate new flavors in the alcoholic, non-alcoholic, dairy, savory, confectionery, and nutraceutical categories, Synergy says.
What Role Should DNA Barcoding Play in Identifying Botanical Ingredients Today? How Has the Technology Progressed?
Even when DNA barcoding functions in concert with other methods in a comprehensive testing toolbox, it still faces hurdles to optimal utility.
Nutritional Outlook recently spoke with Ellen Schutt, GOED’s new executive director, about how, under her leadership, the organization plans to identify market opportunities to move the omega-3 category forward.
Supplier Sabinsa Discusses Ayurvedic Ingredients Market, Adulteration, Research in the Dietary Supplement Industry
Shaheen Majeed, president, Sabinsa worldwide, spoke to Nutritional Outlook about how Sabinsa has navigated 30 years of regulatory change, and how the company plans to continue to deliver science-backed, innovative ingredients for a growing range of health categories.
The new Greenwood, South Carolina, facility will add 50,000 sq ft of manufacturing space to Lonza’s existing specialty ingredients production.